CoChat
Sign Up
Cited by 1,324

The DOI matches its Crossref record.

Bee and Wasp Venoms: The biochemistry and pharmacology of their peptides and enzymes are reviewed.

Habermann, E.·1972·Science
DOI 10.1126/science.177.4046.314
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1126/science.177.4046.314

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 83

  1. ABRAHAMS G THESIS U WURZBURG (1955).
  2. ALBL F THESIS U WURZBURG (1956).
  3. ANASTASI, A, PHARMACOLOGICAL DATA ON PHYLLOKININ (BRADYKINYL-ISOLEUCYL-TYROSINE O-SULPHATE) AND BRADYKINYL-ISOLEUCYL-TYROSINE, BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 27: 479 (1966). · DOI
  4. ARAVINDAKSHAN, I, OXIDATIVE PHOSPHORYLATION IN BRAIN AND LIVER MITOCHONDRIA OF ANIMALS INJECTED WITH COBRA VENOM, BIOCHIMICA ET BIOPHYSICA ACTA 31: 463 (1959). · DOI
  5. BARKER, S.A., CHARACTERIZATION OF PRODUCTS OF ACTION OF BEE VENOM HYALURONIDASE, NATURE 199: 693 (1963). · DOI
  6. BHOOLA, K.D., IDENTIFICATION OF ACETYLCHOLINE, 5-HYDROXY-TRYYPTAMINE, HISTAMINE, AND A NEW KININ IN HORNET VENOM (V CRABRO), JOURNAL OF PHYSIOLOGY-LONDON 159: 167 (1961). · DOI
  7. BRAGANCA, B.M., ENZYME INHIBITIONS BY SNAKE VENOMS, BIOCHEMICAL JOURNAL 53: 88 (1953). · DOI
  8. BREITHAUPT, H, MCD-PEPTIDE FROM BEE VENOM - ISOLATION BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES, NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE 261: 252 (1968). · DOI
  9. BRUCHHAUSEN F.T. THESIS U WURZBURG (1955).
  10. CALLEWAERT, G.L., FED EUR BIOCHEM SOC 1: 111 (1968). · DOI
  11. CHANGEUX, J.P., USE OF A SNAKE VENON TOXIN TO CHARACTERIZE CHOLINERGIC RECEPTOR PROTEIN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 67: 1241 (1970).
  12. CONDREA, E, TOXICON 2: 261 (1965). · DOI
  13. DAKHIL, T, HYDROPEROXYDE ALS TRAGER DER DARMERREGENDEN WIRKUNG HOCHUNGESATTIGTER FETTSAUREN, NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE 243: 174 (1962).
  14. DORMAN, L.C., SOLID PHASE SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF N-TERMINAL SEQUENCES OF MELITTIN, JOURNAL OF MEDICINAL CHEMISTRY 14: 5 (1971). · DOI
  15. EMMELIN, N, THE MECHANISM OF THE STING OF THE COMMON NETTLE (URTICA-URENS), JOURNAL OF PHYSIOLOGY-LONDON 106: 440 (1947). · DOI
  16. FREDHOLM, B, HISTAMINE RELEASE FROM RAT MAST CELLS INDUCED BY A MAST CELL DEGRANULATING FRACTION IN BEE VENOM, ACTA PHYSIOLOGICA SCANDINAVICA 69: 304 (1967). · DOI
  17. FREDHOLM, B, STUDIES ON A MAST CELL DEGRANULATING FACTOR IN BEE VENOM, BIOCHEMICAL PHARMACOLOGY 15: 2037 (1966). · DOI
  18. FREDHOLM, B, BIOCHEM PHARMACOL 71: 357 (1967).
  19. FREDHOLM, B, BIOCHEM PHARMACOL 76: 288 (1969).
  20. FRIMMER, M, DTSCH MED WSCHR 91: 33 (1966). · DOI
  21. GERLICH, N, *DIE BESTIMMUNG DER ZENTRAL-NERVOSEN WIRKUNG DES BIENENGIFTES UND DES GIFTES VON LACHESIS JARARACU, NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE 211: 97 (1950).
  22. GREEN, D.E., ROLE OF LIPIDS IN MITOCHONDRIAL ELECTRON TRANSFER AND OXIDATIVE PHOSPHORYLATION, BIOCHIMICA ET BIOPHYSICA ACTA 70: 554 (1963). · DOI
  23. HABERMANN, E, WIRKUNG DER PHOSPHOLIPASEN A UND C AUF PLASMALIPOIDE UND ERYTHROZYTEN IN VIVO, BIOCHEMICAL PHARMACOLOGY 11: 400 (1962). · DOI
  24. HABERMANN, E, EIGENSCHAFTEN UND ANREICHERUNG DER HYALURONIDASE VON BIENENGIFT, BIOCHEMISCHE ZEITSCHRIFT 329: 1 (1957).
  25. HABERMANN, E, EIN NEUES VERFAHREN ZUR GEWINNUNG DER KOMPONENTEN VON BIENENGIFT INSBESONDERE DES ZENTRALWIRKSAMEN PEPTIDS APAMIN, BIOCHEMISCHE ZEITSCHRIFT 341: 451 (1965).
  26. HABERMANN, E, ZUR BIOCHEMIE DER BIENENGIFTPEPTIDE MELITTIN UND APAMIN, BIOCHEMISCHE ZEITSCHRIFT 343: 192 (1965).
  27. HABERMANN, E, ERGEBN PHYSIOL BIOL 60: 220 (1968).
  28. HABERMANN, E, SEQUENZANALYSE DES MELITTINS AUS DEN TRYPTISCHEN UND PEPTISCHEN SPALTSTUCKEN, HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE 348: 37 (1967). · DOI
  29. HABERMANN, E, MODIFICATION OF AMINO GROUPS AND TRYPTOPHAN RESIDUE OF MELITTIN AS AN AID TO STUDIES ON RELATIONSHIP BETWEEN STRUCTURE AND MODE OF ACTION, HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE 351: 884 (1970). · DOI
  30. HABERMANN, E, HEMMUNG DER OXYDATIVEN PHOSPHORYLIERUNG DURCH TIERISCHE GIFTE, NATURWISSENSCHAFTEN 41: 429 (1954).
  31. HABERMANN, E, EINIGE BEZIEHUNGEN ZWISCHEN PEPSITOCIN + PLASMAKININEN, NATURWISSENSCHAFTEN 51: 61 (1964).
  32. HABERMANN, E, NAUNYN SCHMEIDEBERGS 233: 203 (1954).
  33. HABERMANN, E, *ZUR PHARMAKOLOGIE DES MELITTIN, NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE 222: 173 (1954). · DOI
  34. HABERMANN, E, *UNTERSUCHUNGEN UBER DIE HEMMUNG DER BLUTGERINNUNG DURCH BIENENGIFT, NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE 223: 182 (1954).
  35. HABERMANN, E, BEITRAGE ZUR PHARMAKOLOGIE VON PHOSPHOLIPASE-A, NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE 230: 538 (1957).
  36. HABERMAN, E, COMPARATIVE STUDIES OF NATIVE AND SYNTHETIC MELITTINS, NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE 270: 1 (1971). · DOI
  37. HABERMANN E THESIS U WURZBURG (1955).
  38. HABERMANN, E, Z GES EXPT MED 129: 436 (1958). · DOI
  39. HABERMANN, E, Z GES EXP MED 130: 19 (1958). · DOI
  40. HAHN, G, The bee venom, II announcement - The magnesium content of bee venom, BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT 69: 2764 (1936). · DOI
  41. HAUX, P, SEQUENZANALYSE DES BIENENGIFT-NEUROTOXINS (APAMIN) AUS SEINEN TRYPTISCHEN UND CHYMOTRYPTISCHEN SPALTSTUCKEN, HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE 348: 737 (1967).
  42. HAUX, P, Z PHYSIOL CHEM 350: 536 (1969). · DOI
  43. HEGNER, D, ENZYMSYSTEME IN LYSOSOMENMEMBRANEN NORMALER LEUKOCYTEN, NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE 257: 282 (1967).
  44. HEGNER, D, EFFECT OF MELITTIN ON ISOLATED LYSOSOMAL GRANULES AND POLYMORPHONUCLEAR LEUCOCYTES IN VITRO, NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE 261: 118 (1968). · DOI
  45. HIGGINBOTHAM, R.D., SIGNIFICANCE OF MAST CELL RESPONSE TO BEE VENOM, JOURNAL OF IMMUNOLOGY 106: 233 (1971). · DOI · Paper page
  46. HOGBERG, B, FURTHER OBSERVATIONS ON THE DISRUPTION OF RAT MESENTERY MAST CELLS CAUSED BY COMPOUND 48-80, ANTIGEN-ANTIBODY REACTION, LECITHINASE A AND DECYLAMINE, ACTA PHYSIOLOGICA SCANDINAVICA 48: 133 (1960). · DOI
  47. JAQUES, R, THE PRESENCE OF HISTAMINE, 5-HYDROXYTRYPTAMINE AND A POTENT, SLOW CONTRACTING SUBSTANCE IN WASP VENOM, BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 9: 53 (1954). · DOI
  48. JENTSCH, J, FURTHER STUDIES OF AMINO ACID SEQUENCE OF MELITTIN .4. OPTICAL ROTATORY DISPERSION, ZEITSCHRIFT FUR NATURFORSCHUNG PART B-CHEMIE BIOCHEMIE BIOPHYSIK BIOLOGIE UND VERWANDTEN GEBIETE 24: 33 (1969).
  49. KREIL, G, ISOLATION OF N-FORMYLGLYCINE FROM A POLYPEPTIDE PRESENT IN BEE VENOM, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 27: 275 (1967). · DOI
  50. KREIL, G, BIOSYNTHESIS OF MELITTIN, A TOXIC PEPTIDE FROM BEE VENOM - DETECTION OF A POSSIBLE PRECURSOR, EUROPEAN JOURNAL OF BIOCHEMISTRY 20: 344 (1971). · DOI
  51. LEE, C.Y., ELAPID NEUROTOXINS AND THEIR MODE OF ACTION, CLINICAL TOXICOLOGY 3: 457 (1970). · DOI
  52. LOWRY, P.H., ARCHIVES OF BIOCHEMISTRY 145: 338 (1971). · DOI
  53. LUBKE, K, ISOLATION AND STRUCTURE OF NALPHA-FORMYL MELITTIN, EXPERIENTIA 27: 765 (1971). · DOI
  54. LUTZ, F, ISOLATION OF AN ARGININE-RICH POLYPEPTIDE FROM LYSOSOMES OF POLYMORPHOUS NUCLEAR LEUKOCYTES OF CATTLE, NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE 260: 173 (1968). · DOI
  55. MELDRUM, B.S., ACTIONS OF SNAKE VENOMS OF NERVE AND MUSCLE . PHARMACOLOGY OF PHOSPHOLIPASE A AND OF POLYPEPTIDE TOXINS, PHARMACOLOGICAL REVIEWS 17: 393 (1965).
  56. MILEDI, R, ISOLATION OF CHOLINERGIC RECEPTOR PROTEIN OF TORPEDO ELECTRIC TISSUE, NATURE 229: 554 (1971). · DOI
  57. MITCHELL, H.K., MELITTIN - TOXICITY TO DROSOPHILA AND INHIBITION OF ACETYLCHOLINESTERASE, ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 145: 344 (1971). · DOI
  58. MOROZ, C, ANIMAL TOXINS: 303 (1967).
  59. MOUSSATCHE, H, VENOMS: 275 (1956).
  60. NARANJO, P, HANDBOOK OF EXPERIMENTAL PHARMACOLOGY 18: 179 (1966).
  61. NEUMANN, W, ZUR PAPIERELEKTROPHORETISCHEN FRAKTIONIERUNG TIERISCHER GIFTE, NATURWISSENSCHAFTEN 39: 286 (1952). · DOI
  62. NEUMANN, W, *BEITRAGE ZUR CHARAKTERISIERUNG DER WIRKSTOFFE DES BIENENGIFTES, NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE 222: 367 (1954).
  63. NEUMANN, W, VENOMS: 171 (1956).
  64. OWEN, M.D., INSECT VENOMS - IDENTIFICATION OF DOPAMINE AND NORADRENALINE IN WASP AND BEE STINGS, EXPERIENTIA 27: 544 (1971). · DOI
  65. PISANO, J.J., HANDBOOK OF EXPERIMENTAL PHARMACOLOGY 25: 589 (1970).
  66. REPKE, KRH, UBER DEN EINFLUSS VERSCHIEDENER KARDIOTONISCHER VERBINDUNGEN AUF DIE TRANSPORT-ATPASE IN DERZELLMEMBRAN DES HERZMUSKELS, NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE 245: 59 (1963).
  67. ROCHAT, C, PURIFICATION AND SOME PROPERTIES OF NEUROTOXINS OF ANDROCTONUS AUSTRALIS HECTOR, BIOCHEMISTRY 6: 578 (1967). · DOI
  68. ROTHSCHILD, A.M., HISTAMINE RELEASE BY BEE VENOM PHOSPHOLIPASE A AND MELLITIN IN RAT, BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 25: 59 (1965). · DOI
  69. SALZMANN G THESIS U WURZBURG (1953).
  70. SCHACHTER, M, KININS OF DIFFERENT ORIGINS, ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 104: 108 (1963). · DOI
  71. SCHACHTER, M, CHEMICAL AND PHARMACOLOGICAL PROPERTIES OF THE POTENT, SLOW CONTRACTING SUBSTANCE (KININ) IN WASP VENOM, BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 9: 352 (1954). · DOI
  72. SCHMIDT, H, PHOSPHOLIPASE A - EIN MOGLICHERWEISE ENTSCHEIDENDER FAKTOR IN DER PATHOGENESE DER AKUTEN PANKREATITIS, KLINISCHE WOCHENSCHRIFT 45: 163 (1967). · DOI
  73. SCHRODER, E, EXPERIENTIA: 764 (1971).
  74. SESSA, G, INTERACTION OF A LYTIC POLYPEPTIDE, MELITTIN, WITH LIPID MEMBRANE SYSTEMS, JOURNAL OF BIOLOGICAL CHEMISTRY 244: 3575 (1969). · DOI
  75. SHIPOLINI, R, STRUCTURE OF APAMIN, CHEMICAL COMMUNICATIONS: 679 (1967).
  76. SHIPOLINI, R.A., PHOSPHOLIPASE-A FROM BEE VENOM, EUROPEAN JOURNAL OF BIOCHEMISTRY 20: 459 (1971). · DOI
  77. SHIPOLINI, R.A., PRIMARY SEQUENCE OF PHOSPHOLIPASE-A FROM BEE VENOM, FEBS LETTERS 17: 39 (1971). · DOI
  78. SLOTTA, K.H., IDENTIFICATION OF DIRECT LYTIC FACTOR FROM COBRA VENOM AS CARDIOTOXIN, TOXICON 6: 167 (1969). · DOI
  79. STOCKEBRAND P THESIS U WURZBURG (1965).
  80. THON, I.L., DEGRANULATION AND HISTAMINE RELEASE 2 CONSECUTIVE STEPS IN RESPONSE OF RAT MAST CELLS TO COMPOUND 48/80, ACTA PHYSIOLOGICA SCANDINAVICA 71: 303 (1967). · DOI
  81. VANDEENEN, LLM, PHOSPHOGLYCERIDES AND PHOSPHOLIPASES, ANNUAL REVIEW OF BIOCHEMISTRY 35: 157 (1966). · DOI
  82. WALDVOGEL, G, ON LOCALISATION OF INCREASED VASCULAR PERMEABILITY, NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE 258: 321 (1967). · DOI
  83. WELLHONER, H.H., SPINAL ACTIONS OF APAMIN, NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE 262: 29 (1969). · DOI

Cited by

Sorted by citations

Metadata

Authors
Habermann, E.
Venue
Science
Publisher
American Association for the Advancement of Science (AAAS)
Published
1972-07-28
Volume
177
Issue
4046
Pages
314-322
ISSN
  • 0036-8075
  • 1095-9203
DOI
10.1126/science.177.4046.314
Cited by
1,324
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review